Stock vs Stock Comparison

Autolus Therapeutics plc vs Absci Corporation

ABSI wins the Tale of the Tape 4–3.

AUTL
ABSI$5.94

🏆 Tale of the Tape

34
AUTLABSI
-381.4%Profitability (Net Margin)-4113.7%
-38.1%Efficiency (ROIC)-46.9%
2/9Health (Piotroski F)2/9
Safety (Altman Z)5.1
644.9%Growth (Rev YoY)-38.2%
Risk (Sharpe 1Y)0.56
2.31xBalance Sheet (D/E)0.14x
FCF Yield-21.57%

Green = winner in each category. Higher is better except P/E (lower = cheaper).

Fundamentals

MetricAUTLABSI
Market Cap$1.1B
P/E Ratio
Forward P/E-10.6x
P/B6.10x
Dividend Yield
Beta2.38

Quantitative Metrics

MetricAUTLABSI
DCF Fair Value
DCF Upside
Piotroski F2/92/9
Altman Z5.11
Beneish M2.86
FCF Yield-21.57%
Net Debt/EBITDA
ROIC-38.1%-46.9%
WACC
ROIC – WACC
Gross Margin-27.8%
Net Margin-381.4%-4113.7%
Rev Growth YoY644.9%-38.2%
Sharpe (1Y)0.56
Max Drawdown 3Y-66.1%
FCF Payout Ratio

AUTL Price

Loading chart...

ABSI Price

Loading chart...

ETF Exposure

AUTL found in:

GWX0.02%

ABSI found in:

ARKG4.81%
XBI0.32%

More Comparisons

Quant metrics computed from financial statements and 1,200+ trading days. Correlation is Pearson coefficient on daily log returns. Not investment advice.

AUTL vs ABSI: Head-to-Head Analysis

Autolus Therapeutics plc (AUTL) and Absci Corporation (ABSI) represent two companies in the Healthcare sector. In our quantitative Tale of the Tape scoring, ABSI leads 4–3 across nine fundamental and risk metrics including profitability, valuation, capital efficiency, and financial health.

In terms of capital efficiency, AUTL generates a return on invested capital (ROIC) of -38.1% compared to ABSI's -46.9%. This suggests AUTL is more effective at deploying capital to generate shareholder returns.

AUTL appears in 1 ETF tracked by SecuritiesDB, while ABSI appears in 2 ETFs. Investors holding broad-market ETFs may already have indirect exposure to both stocks.

Frequently Asked Questions

Which stock is the better investment, AUTL or ABSI?

Our quantitative analysis compares AUTL and ABSI across nine fundamental dimensions. ABSI wins the Tale of the Tape 4–3. However, stock selection depends on your individual risk tolerance, time horizon, and portfolio context. These metrics are computed from SEC filings and market data — they are not investment recommendations.

Are AUTL and ABSI correlated?

Correlation data is not yet available for this pair. Check back after both stocks have sufficient trading history.

How is the Tale of the Tape scored?

The Tale of the Tape compares both stocks across nine categories: profitability (net margin), valuation (P/E), efficiency (ROIC), health (Piotroski F-Score), safety (Altman Z-Score), growth (revenue YoY), risk (Sharpe ratio), leverage (debt-to-equity), and cash generation (FCF yield). The stock that wins more categories takes the overall score. Lower P/E and lower debt-to-equity count as wins.